Search results
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Motley Fool via Yahoo Finance· 2 months agoSince 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%....
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Is This a Good Sign for Novavax?
Motley Fool· 10 months agoNovavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. The biotech stock has been in the doldrums ever since the company...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 2 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
Is This the Telltale Sign to Sell Novavax Stock?
Motley Fool· 1 year agoUnfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine,...
Novavax Stock: Buy, Sell, or Hold in 2023?
Motley Fool· 1 year agoIn the early days of the pandemic, investors bet Novavax (NASDAQ: NVAX) would be a coronavirus vaccine winner. When the biotech's vaccine candidate fell...